Gene: ALG5
Official Full Name: ALG5 dolichyl-phosphate beta-glucosyltransferaseprovided by HGNC
Gene Summary: This gene encodes a member of the glycosyltransferase 2 family. The encoded protein participates in glucosylation of the oligomannose core in N-linked glycosylation of proteins. The addition of glucose residues to the oligomannose core is necessary to ensure substrate recognition, and therefore, effectual transfer of the oligomannose core to the nascent glycoproteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27010 | ALG5 Knockout cell line (HeLa) | Human | ALG5 | 1:3~1:6 | Negative | Online Inquiry |
KO27011 | ALG5 Knockout cell line (HCT 116) | Human | ALG5 | 1:2~1:4 | Negative | Online Inquiry |
KO27012 | ALG5 Knockout cell line (HEK293) | Human | ALG5 | 1:3~1:6 | Negative | Online Inquiry |
KO27013 | ALG5 Knockout cell line (A549) | Human | ALG5 | 1:3~1:4 | Negative | Online Inquiry |
ALG5 Gene Knockout Cell Lines represent a cutting-edge biological tool designed for researchers aiming to study the functional implications of the ALG5 gene, which encodes a critical enzyme involved in the N-glycosylation pathway. This knockout model effectively eliminates the expression of the ALG5 gene, providing a unique platform to investigate the cellular and systemic impacts of disrupted glycoprotein maturation processes. By utilizing CRISPR-Cas9 gene editing technology, ALG5 Gene Knockout Cell Lines ensure precise and efficient disruption of the target gene, generating stable cell lines ready for downstream applications.
The key functions of these cell lines are centered on their ability to facilitate the analysis of cellular mechanisms relating to protein folding, stability, and function, particularly within the context of glycosylation processes. ALG5 is pivotal in the conversion of UDP-GlcNAc to GlcNAc-pyrophosphate, and its knockout can lead to alterations in glycan composition on glycoproteins, which is paramount for understanding various pathological states, including cancer and congenital disorders.
The scientific importance of ALG5 Gene Knockout Cell Lines lies in their applicability in both research and clinical settings, allowing for the exploration of novel therapeutic targets and the validation of drug efficacy in diseases affected by glycosylation defects. Compared to other genetic models, these knockout lines offer enhanced accuracy and specificity in modeling gene function, enabling researchers to derive clearer insights and more reproducible results.
Researchers and clinicians stand to gain significantly from the use of ALG5 Gene Knockout Cell Lines. The ability to conduct in-depth investigations into glycoprotein abnormalities connected to numerous diseases empowers scientists to craft innovative therapeutic strategies and biomarkers. The comprehensive support offered by our company, with its expertise in gene editing technologies and dedication to advancing scientific discovery, further ensures that customers can effectively harness the potential of these valuable biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.